A Study Assessing KB304 for the Treatment of Wrinkles in Women

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

August 31, 2025

Conditions

Wrinkles in DecolletagePigmentationDécolleté Wrinkles

Interventions

BIOLOGICAL

KB304

Genetically modified herpes simplex type 1 virus

DRUG

0.9% Normal Saline (NS)

Placebo

Trial Locations (1)

Steve Yoelin Medical Associates, Newport Beach